Cargando…
Recent trend in gastric cancer treatment in the USA
Gastric adenocarcinoma (GAC) is estimated as the fifteenth most common cancer in the USA. Incidence rate has been gradually decreasing, but prognosis remains dismal. For patients with locally advanced GAC (stage > T1B and < T4B), multimodality therapies, such as surgery, chemotherapy, and radi...
Autores principales: | Harada, Kazuto, Baba, Hideo, Ajani, Jaffer A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8188734/ https://www.ncbi.nlm.nih.gov/pubmed/34113719 http://dx.doi.org/10.20517/2394-4722.2017.74 |
Ejemplares similares
-
Recent advances in the management of gastric adenocarcinoma patients
por: Harada, Kazuto, et al.
Publicado: (2018) -
Recent advances in preoperative management of esophageal adenocarcinoma
por: Harada, Kazuto, et al.
Publicado: (2017) -
Recent advances in treating oesophageal cancer
por: Harada, Kazuto, et al.
Publicado: (2020) -
Recent advances in the management of gastric adenocarcinoma patients
por: Rogers, Jane E, et al.
Publicado: (2023) -
Attenuation of YAP1 can potentially target cancer stem cells to overcome drug resistance
por: Harada, Kazuto, et al.
Publicado: (2018)